Health Care
(E91Z)
990 on File
LUTHERAN HOME OF CENTRAL NEW YORK
Financial strength (30%)
78/100
Reliability (20%)
50/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$2.0M
Total Revenue
$2.4M
Total Expenses
$9.9M
Net Assets
58
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.5%
Fundraising Efficiency
N/A
Operating Reserve
48.82x
Liability-to-Asset
19.2%
Revenue Diversification
84.3%
Compared with Peers
FY 2023
Compared with 4,434 similar organizations
(United States, Health Care, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.5% | 84.9% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
22.5% | 11.8% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
48.8 mo | 9.7 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
19.2% | 14.7% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
84.3% | 91.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-28.3% | 5.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.2% | 9.2% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-23.5% | 1.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2.0M | $2.4M | $9.9M | 77.5% | 58 |
| 2022 | $2.7M | $2.3M | $9.4M | 82.9% | 66 |
| 2021 | $2.4M | $2.5M | N/A | — | 82 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.